Healing and recovery research peptides

BPC-157, TB-500, KPV and Thymosin Alpha-1, with the Wolverine Stack blend, supplied in Canada as lyophilised research material for laboratory use. The category name describes the research fields these compounds are studied in, not anything the material in a vial does.

BPC-157 is a synthetic 15-amino-acid sequence examined almost entirely in rodent tendon, ligament, muscle and gastrointestinal injury models, much of it from a small number of research groups. TB-500 is a fragment of thymosin beta-4, studied in animals for actin sequestration and cell migration; data on the full protein is not data on the fragment. Both are preclinical, neither is approved, and both are prohibited in sport by WADA. The Wolverine Stack combines the two, and no study has examined that combination.

KPV, the C-terminal tripeptide of alpha-MSH, is studied in rodent colitis and skin-inflammation models and in NF-κB pathway work. Thymosin Alpha-1 is the exception in this group: it has human trial data, largely from outside North America, and is approved in some countries, though not in Canada or the United States.

Every lot carries a published third-party certificate of analysis.

Supplied for laboratory research use only, not for human or veterinary use. Certificates for every lot are on testing results.